BioWisdom Releases Text Analytics Version of OmniViz for Patent Specialists

CAMBRIDGE, England, Oct. 23 /PRNewswire/ -- BioWisdom Ltd (BioWisdom), the
market leader in delivering healthcare intelligence to the pharmaceutical
industry, today announces the release of OmniViz Visualization Software for
Patent Specialists.
Patent data are increasingly being used in competitive business and
technical intelligence analyses to impact research and business decisions.
OmniViz Visualization Software can turn the analysis of thousands of patents
into a straightforward and rapid process.
"OmniViz is unique in being able to analyze thousands of patent documents,
automatically analyzing trends and associations that is just not possible with
any other product on the market today," said Chris Hodkinson, COO of
BioWisdom. "Coupling this capability with the ability of searching and
loading patent data with BioWisdom's Patent Harvester provides real
competitive advantage."
For more information about OmniViz visit
http://www.biowisdom.com/content/omniviz

Notes to Editors
ABOUT BIOWISDOM
BioWisdom delivers intelligence for the Healthcare Industry and helps
clients to navigate the complex scientific and commercial issues involved in
developing successful healthcare products. The company provides a powerful
suite of software tools for the formatting, search, visualization and high
value analysis of healthcare intelligence. The BioWisdom team combines
extensive experience of the pharmaceutical and biotechnology industries with
proven expertise in life science software development.
For more information, please visit http://www.biowisdom.com
SOURCE BioWisdom Ltd

Bruce McPherson of BioWisdom Ltd, +1-978-461-1250, info@biowisdom.com